TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan · Delayed Price · Currency is TWD 6.78
-0.10 (-1.45%)
Sep 11, 2026, 2:05 PM CST
TaiwanJ Pharmaceuticals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -18.35 | -24.34 | -22.34 | -6.05 | -92.47 | -12.42 |
Depreciation & Amortization | 1.59 | 1.61 | 1.89 | 2.01 | 76.47 | 1.16 |
Stock-Based Compensation | 0.09 | 0.21 | 0.45 | 1.38 | 0.59 | -0.01 |
Provision & Write-off of Bad Debts | -3.07 | - | - | - | 10.75 | - |
Other Operating Activities | -2.6 | -0.77 | -2.1 | -2.52 | -0.49 | -0.04 |
Change in Accounts Receivable | 3.1 | 0.03 | 0.19 | 4.61 | -15.36 | - |
Change in Accounts Payable | -0.16 | -0.71 | -0.2 | -0.89 | -0.14 | 0.11 |
Change in Other Net Operating Assets | -0.06 | -0.2 | -0.52 | 0.63 | -0.42 | 1.16 |
Operating Cash Flow | -19.47 | -24.17 | -22.62 | -0.82 | -21.07 | -10.05 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.29 | - | -1.44 | -1.23 | - |
Investment in Securities | 40 | 40 | -40 | - | - | - |
Other Investing Activities | 5.94 | 6.14 | 2.1 | 1.09 | 0.67 | 0.04 |
Investing Cash Flow | 45.94 | 45.85 | -37.9 | -0.35 | -0.56 | 0.04 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.74 | -0.7 | -0.69 | -0.56 | -0.56 |
Lease Payments | -0.98 | -0.74 | -0.7 | -0.69 | -0.56 | -0.56 |
Net Debt Issued (Repaid) | -0.98 | -0.74 | -0.7 | -0.69 | -0.56 | -0.56 |
Issuance of Common Stock | - | - | 50 | - | - | - |
Financing Cash Flow | -0.98 | -0.74 | 49.3 | -0.69 | -0.56 | -0.56 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 1.27 | -0.72 | - | - | - | - |
Net Cash Flow | 26.75 | 20.22 | -11.22 | -1.86 | -22.19 | -10.57 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -19.47 | -24.46 | -22.62 | -2.26 | -22.3 | -10.05 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | - | -9.95% | -145.22% | -45.56% |
Free Cash Flow Per Share | -0.24 | -0.30 | -0.30 | -0.03 | -0.30 | -0.13 |
Levered Free Cash Flow | -11.76 | -14.98 | -15.04 | 2.15 | 10.41 | -3.68 |
Unlevered Free Cash Flow | -11.72 | -14.95 | -15.03 | 2.17 | 10.42 | -3.67 |
Free Cash Flow After Leases | -20.45 | -25.2 | -23.32 | -2.95 | -22.86 | -10.61 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.07 | 0.05 | 0.01 | 0.02 | 0.01 | 0.01 |
Cash Income Tax Paid | - | -0.16 | - | 2.27 | - | 2.11 |
Change in Working Capital | 2.88 | -0.88 | -0.53 | 4.35 | -15.91 | 1.27 |